 |
Articles: Biotechnology |
Prior Articles
Nabi Biopharmaceuticals Prevails in Opposition Hearing for NicVAX Patent
Corporate News Releases - The Healthcare Sales & Marketing Network, 05/07/08
Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
Dendreon Coproration, 05/05/08 Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
Corporate News Releases - The Healthcare Sales & Marketing Network, 05/02/08 Pharmaceutical and Biotechnology Middle East gets underway
Corporate News Releases - The Healthcare Sales & Marketing Network, 04/29/08 Environmental Tectonics Corporation's BioMedical Division Announces Sale of Two Hyperbaric Chambers
Corporate News Releases - The Healthcare Sales & Marketing Network, 04/29/08 Hana Biosciences Appoints Anne E. Hagey, M.D., Vice President and Chief Medical Officer
Corporate News Releases - The Healthcare Sales & Marketing Network, 04/29/08 CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership
Corporate News Releases - The Healthcare Sales & Marketing Network, 04/28/08 ImmuneRegen(R) and BioCure Collaborate on Novel Wound-Healing Product
Corporate News Releases - The Healthcare Sales & Marketing Network, 04/28/08 Ocimum Biosolutions Launches Genowiz 4.0, A Compre
PharmiWeb, 04/25/08 Dendreon Presents Data Correlating the Cumulative Potency of PROVENGEA® to Overall Survival
Dendreon Coproration, 04/24/08 Dendreon Publishes Manuscript on CD54 as a Surrogate Marker of Antigen Presenting Cell Activation
Dendreon Coproration, 04/24/08 Dendreon Receives European Patent Covering PROVENGE and Companys ACI Platform Technology
Dendreon Coproration, 04/24/08 Archemix' ARC1779 Granted Orphan Designation for the Treatment of TTP, a Life-Threatening Blood Disorder
Corporate News Releases - The Healthcare Sales & Marketing Network, 04/24/08 Dr. Gary Piazzo to present at GTCbio's 3rd Assay Development & Screening Technologies Conference
PharmiWeb, 04/22/08 Cytokinetics Announces Selection of Development Compound that Activates the Skeletal Sarcomere
Cytokinetics, 04/21/08 Preclinical Study Shows CTIs Brostallicins Cancer-Killing Ability Based on Genetic Profiling
Cell Therapeutics, 04/16/08 Drug Pooling: Power and Pitfalls
Applied Clinical Trials, 04/15/08 New Gene Discovery Suggests Which Patients CTIs Brostallicin May Benefit
Cell Therapeutics, 04/15/08 UPDATE 2-Genentechs Rituxan not effective in type of MS
Corporate News Releases - The Healthcare Sales & Marketing Network, 04/15/08 Genzyme Genetics Announces Launch of Carrier Testing and Prenatal Diagnosis for Spinal Muscular Atrophy
Genzyme, 04/15/08
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
79 Available Pages
|
|
